• Home
  • Lifetech Products
  • R & D
  • News
  • Investor Relations
  • About Us
中文
  • Company Profile
  • Finanical Report
  • Announcement
  • IR Contact
  • 2023-01-05

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022

     
  • 2022-12-13

    VOLUNTARY ANNOUNCEMENT - Enrollment in the China Randomized Controlled Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed

     
  • 2022-12-05

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2022

     
  • 2022-11-03

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2022

     
  • 2022-10-20

    VOLUNTARY ANNOUNCEMENT - Admission of Innovative Medical Devices in respect of Aortic Arch Stent Graft System (Fenestration) into Special Examination and Approval Procedure

     
  • 2022-10-05

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2022

     
  • 2022-09-05

    FDA Approved Investigator-initiated Pre-market Clinical Trial of LAmbreTM Plus LAA Closure System Obtained Medical Insurance Coverage in the US

     
  • 2022-09-02

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2022

     
  • 2022-08-30

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022

     
  • 2022-08-12

    NOTICE OF BOARD MEETING

     
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Legal Notice|Contact Us||Site Map
-->

Lifetech WeChat

Links

Links...
  • Twitter
  • Linked
  • clhweb
Copyright © 2008-2020 Lifetech Scientific, All rights reserved.